Molecule Information
General Information of the Molecule (ID: Mol02106)
Name |
High-affinity pentamidine transporter (HAPT1)
,Trypanosoma
|
||||
---|---|---|---|---|---|
Synonyms |
HAPT1
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
HAPT1
|
||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
IDUE: Irregularity in Drug Uptake and Drug Efflux
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Pentamidine
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: African trypanosomiasis | [1] | |||
Resistant Disease | African trypanosomiasis [ICD-11: 1F51.0] | |||
Resistant Drug | Pentamidine | |||
Molecule Alteration | Expression | Down-regulation |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Trypanosoma brucei strain | 5691 | ||
Mechanism Description | While a high level of resistance to diminazene was observed, the resistance factor for pentamidine and the melaminophenyl arsenicals were only two to threefold, significantly less than the arsenical-pentamidine cross-resistant strains generated in the laboratory. Thus, it was clear that at least one additional transporter must contribute to the cross-resistance phenotype. The prime candidate was the high-affinity pentamidine transporter (HAPT1), an activity recorded in bloodstream-form T. brucei using low nanomolar concentrations of [3H]-pentamidine. Melarsoprol also appears to be a substrate for HAPT1 and selection for increased resistance to pentamidine or melarsoprol in Tbat1 null cells led to specific loss of HAPT1 activity. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.